InvestorsHub Logo
Followers 2
Posts 1798
Boards Moderated 0
Alias Born 01/05/2017

Re: chainma1l post# 47141

Friday, 12/22/2017 3:03:45 PM

Friday, December 22, 2017 3:03:45 PM

Post# of 108192
"Preliminary Stage 1 results from 29 of the planned evaluable patients showed 1 (3.5%) patient had a durable partial response lasting > 6 months (after progression on prior anti-PD-1 therapy) and 7 had stable disease (24%). Disease control rate was 28%. The current Kaplan Meier 6-month PFS estimate is 22%, indicating the trial met the criteria to proceed to Stage 2 of enrollment. "

Does this mean ADXS beat past statistics of 22% in FAWCETT?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News